Transforming growth factor I8 (TGF-1) has potent down-regulating effects on macrophages and is thus capable of influencing the fate of intramacrophage parasites, including leishmanias. We report the development of a mouse model for the study of the human pathogen Leishmania braziliensis and demonstrate, both in vitro and in vivo, a key regulatory role for TGF-fi in the pathogenesis of infection with this parasite. Recombinant TGF-fi added to cultures of murine peritoneal macrophages led to increased intracellular L. braziliensis replication, whereas addition of neutralizing anti-TGF-fi monoclonal antibody decreased levels of infection.
TGF-fi monoclonal antibody decreased levels of infection.
Macrophages infected with L. braziliensis produced biologically active TGF-(3, with a direct correlation between amounts of TGF-13 induced by two parasite isolates and their relative virulence. In vivo, treatment with recombinant TGF-fi rendered avirulent parasites virulent and activated latent L. braziliensis infection. Activation of parasite replication was observed in mice which had been infected with L. braziliensis 15 weeks previously but had not developed lesions or had healed lesions, depending on the parasite isolate used to infect the mice. The exacerbation of L. braziliensis infection in vivo was associated with an increase of interleukin 10 mRNA in the draining lymph node. These results demonstrate that TGF-13 is able to alter the course of in vitro and in vivo infections with L. braziliensis, the latter being characterized by an increase in interleukin 10, an important Th2 helper-T-cell cytokine.
Leishmanias are intracellular protozoan parasites transmitted to humans and other mammals by the bite of a sandfly. They cause a variety of human diseases characterized by visceral, cutaneous, or mucosal lesions. The different species and isolates of these obligate macrophage parasites vary considerably in their ability to infect and replicate in these host cells in vitro or in vivo. For example, both Leishmania major and Leishmania amazonensis multiply rapidly in human and mouse macrophages in vitro and readily infect mice, whereas Leishmania braziliensis has been reported to be relatively less infectious for cultivated macrophages or mice (1) . No clear associations have been made between inter-or intraspecies properties and virulence, although the developmental stage of the parasite is important for infectivity (2) .
Clinically, infections with L. braziliensis present as single or multiple cutaneous lesions, with a small percentage of individuals progressing to more severe mucosal disease (3, 4) . While the cutaneous lesions may heal spontaneously or respond well to chemotherapy, mucosal lesions are often highly destructive and are relatively refractory to treatment. Even if the mucosal lesion heals, there is often spontaneous relapse, perhaps years later. Largely due to difficulties in establishing a mouse model, there have been relatively few studies on immunoregulatory aspects of L. braziliensis infections.
The present study was undertaken to determine the potential role of transforming growth factor f (TGF-,B) in the control of L. braziliensis infection. This important cytokine has a variety of immunological effects (5) (6) (7) (8) . These include inactivation of physiological processes of macrophages (9, 10) , thus influencing the ability of these cells to control intracellular parasites, including leishmanias and Trypanosoma cruzi (11, 12) . Of particular interest is the finding that TGF-f3 can block the effects of interferon y (IFN-y), a cytokine important in mediating parasite destruction (12) . In mice, a healing response to leishmanial infection has been associated with the production of IFN-y, a Thi helper-T-cell cytokine, and a non-healing response with the production of Th2 cytokines, including interleukin 4 (IL-4) and IL-10 (13) (14) (15) .
It is apparent that the pattern of cytokine expression is closely linked to the outcome of leishmanial infection. Therefore, processes which influence this pattern play critical roles in the disease process. We demonstrate in this study that biologically active TGF-P, a cytokine capable of blocking the utilization of IFN-y, is induced following L. braziliensis infection and that TGF-P plays an important role in regulating in vitro and in vivo infection with this parasite. Further 
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Lesion progression was evaluated during the course of infection by footpad thickness measured with a dial gauge caliper (C. Starret, Athol, MA), and expressed as lesion size in millimeters (infected footpad thickness minus uninfected contralateral footpad thickness). At various times after infection, animals were killed, and infected feet were removed, fixed in buffered 10% formalin, processed, and stained with hematoxylin and eosin.
Macrophage Cultures and Infection. Thioglycolate-stimulated mouse peritoneal macrophages were plated in 24well plates at 5 x 105 cells per well, in RPMI 1640 supplemented with antibiotics, glutamine, and 10%6 heat-inactivated fetal bovine serum. Macrophages were infected with stationaryphase L. braziliensis promastigotes (2.5 x 106 parasites per well) for 3 hr. Extracellular parasites were removed by extensive washings with warm culture medium, followed by further incubation for up to 72 hr. Cell-free supematants were collected at 24, 48, or 72 hr after infection. Replicate monolayers were washed with phosphate-buffered saline, fixed in methanol, and stained with Giemsa reagent. The percentage of infected macrophages and the number of amastigotes per 100 macrophages were determined by microscopic examination as described (16) . In some cultures rTGF-/3 ( Assay for Active TGF-P. Supernatants from uninfected and leishmania-infected macrophage cultures were assayed for active TGF-P by using CCL-64 mink lung epithelial cells as described (18) . Latent TGF-,3 will not inhibit growth of CCL-64 cells (19) . The concentration of TGF-,B in each sample was determined by comparison with a curve generated from TGF-,3 standards, computed using the Microsoft GB STAT program. The specificity of the assays was confirmed by inhibition with 1D11. 16 anti-TGF-, mAb.
Cytokine PCR. RNA was isolated from mouse cells by acid guanidinium thiocyanate-phenol/chloroform extraction (20) . One ug of total RNA was reverse-transcribed by the addition of 2.5 units of RNasin (Promega); 25 (Fig. 1) . This suggested that the macrophages were normally capable ofcontrolling the intracellular replication of Leishmania, and that the mechanism(s) responsible for this anti-TGF-,B mAb (200 ,g/ml; hatched bars) 24 hr before and continuously after infection (but not during infection) or in medium alone (cross-hatched bars). Numbers of intracellular parasites were determined 2, 24, and 48 hr after infection. Significant increases in parasite numbers were seen at 48 hr after infection in the TGF--treated cultures (P < 0.05), whereas significant decreases in parasite numbers were seen in the anti-TGF-3-treated cultures (P < 0.05 (Fig. 2) , but the amounts of active TGF-3 produced differed significantly between the two parasite isolates, even though in vitro infection levels did not differ significantly (data not shown). TGF-f3 was not observed in replicate cultures of parasites alone or in macrophages incubated with comparable numbers of heat-killed parasites. This finding confirmed our earlier observation on the production of active TGF-f3 by leishmania-infected macrophages (21) and suggested a potentially important and quantifiable difference related to infection with different isolates of a given species.
Exacerbation of in Vivo Leishmanial Infection by TGF-fi. The preceding in vitro observations suggested a differential ability of leishmania isolates to induce active TGF-/3 production, as well as a role for TGF-,/ in the control of L. braziliensis infection. To determine whether the ability to induce TGF-p correlated with parasite virulence, the isolates were used to infect mice, with and without the administration of rTGF-f3. Each of these isolates produced characteristic self-limiting infections in saline-treated mice (Fig. 3) . However, there was a direct correlation between lesion size and TGF-p levels induced by the two parasite isolates. BA-331 was a relatively weak inducer of TGF-,8 in vitro and produced no measurable lesion, whereas BA-92 induced measurable but self-limiting lesions as well as significantly higher in vitro levels of TGF-,B. This observation suggested a role for TGF-P production in leishmanial infectivity and/or intracellular replication in vivo. To test this, exogenous TGF-,3 was administered to groups of mice infected with either of these two L. braziliensis isolates. rTGF-,8 treatment led to a significant increase in mean lesion size in all mice (Fig. 3) . Histologically, the lesions were characterized by large numbers of heavily parasitized macrophages, whereas parasites were not detectable in saline-treated mice (data not shown). The differences between rTGF-,3-treated and saline-treated mice were greatest in those infected with BA-331, which produced 2.0 Weeks after infection Fig. 3B was examined by PCR for the production of cytokines at 10 weeks after infection (Fig. 4) . Serial dilutions of cDNA were used for the PCR to establish a semiquantitative relationship between the groups. Mice infected with L. braziliensis and treated with rTGF-p appeared to have lower levels of IFN-'y and IL-2 mRNA than did similarly infected, saline-treated mice. The most noticeable difference between the two groups was in IL-10 mRNA, which was not detected in uninfected or infected, saline-treated mice with self-healing lesions but was Popliteal nodes from mice treated as in Fig. 3A were removed 10 weeks after infection, and RNA was prepared for cytokine PCR analysis as described in Materials and Methods. N, uninfected mice;
I, infected mice treated with saline (panel 1) or TGF-,/ (panel 2).
cDNA dilutions of 1:10 (a), 1:50 (b), and 1:500 (c) were used for PCR.
relatively abundant in rTGF-/3-treated mice with exacerbated lesion growth. No difference in IL-4 mRNA levels was detected. None ofthese cytokine mRNA levels were elevated in the contralateral lymph nodes from infected mice or in the popliteal nodes of uninfected mice treated with rTGF-/3 (data not shown). Thus, in vivo administration of rTGF-P led to the development of a lesion from L. braziliensis infection, as well as to an increase in IL-10 mRNA in the lymph node draining the infected feet in which lesion development occurred. Activation of Latent L. braziliensis Infections by Administration of Exogenous TGF-g3. Clinically, L. braziliensis infection is often characterized by prolonged intervals between relapsing disease. In mice, L. braziliensis infection leads to transient or no lesion development, as illustrated in Fig. 3 . To determine whether parasites persisted following infection, and whether rTGF-3 could influence prior infections, mice were treated with rTGF-/3 for a 3-week period beginning 15 weeks after infection, a time at which no demonstrable lesion was present. In both groups injection of rTGF-/3, but not saline, led to lesion development, detected by 2-3 weeks after the initiation of treatment (Fig. 5) 
DISCUSSION
The potential importance of TGF-,l in infections with macrophage parasites was suggested by studies which documented the down-regulating effects of this cytokine on class II major histocompatibility complex expression (22) and oxidative metabolism (9). Silva et al. (12) subsequently reported that TGF-p could block macrophage activation in T. cruzi infections and was capable of altering resistance and susceptibility to this organism in vivo. Cytokines which can inactivate macrophage functions, particularly TGF-P and IL-10, are proving to play key roles in the regulation of infections with certain intracellular parasites, including Leishmania (11) and T. cruzi (12, 23) .
In a previous study, we demonstrated that TGF-,8 was produced both in vitro and in vivo following infection of mouse cells with L. amazonensis and that TGF-P administered in vivo could exacerbate infection with either L. amazonensis or L. braziliensis (21) . The present study significantly expands these earlier findings by establishing a direct correlation between the amount of TGF-p produced following in vitro infection and parasite virulence, by demonstrating that exogenous TGF-,B could activate abeyant L. braziliensis infections, and by establishing a correlation between TGF-,-induced lesion development and increased IL-10 mRNA production. These results link TGF-p-mediated leishmaniainduced pathogenesis with the production of a Th2 helper-Tcell response (24) . Increased IL-10 mRNA has also been associated with pathology due to experimental L. major infection (15) . However, there have been no previous reports on the pattern of cytokine production in L. braziliensis infections, due primarily to the lack of a mouse model to study this parasite. The present study provides evidence for a link between two key cytokines, IL-10 and TGF-f3, which are associated with down-regulating immune responses. TGF-,B treatment of uninfected footpads did not increase IL-10 mRNA in the draining lymph nodes. This suggests that the infections exacerbated by TGF-f treatment led to increased IL-10 production. Whether increased IL-10 may itself mediate increased leishmania replication remains to be determined. One possibility is that TGF-,B is essential for regulating early events in determining intramacrophage parasite growth and that uncontrolled growth promotes the development of a Th2 response.
Leishmanias are obligate macrophage parasites. A variety of species infect humans, and most or all of these can cause experimental infection, but not always disease, in mice. An example of the latter is L. braziliensis, for which there has been no good model of the chronic and often recurring disease seen in humans. Our demonstrations that TGF-f3 can exacerbate leishmanial infection and lead to lesion development following injection of normally avirulent (for mice) parasites implicate TGF-P as a key factor in the establishment and control of macrophage infection. Further, the finding that production of active TGF-/3 follows leishmanial infection of macrophages demonstrates that this may be an important mechanism by which intracellular parasites upregulate molecules which favor their survival in host cells. In a related study, it was shown that an uncharacterized com- (1993) ponent(s) of the saliva from the insect vector exacerbated L. braziliensis infection in mice (25) . The relationship between sandfly material and TGF-P3, including the possibility that vector-associated components can induce macrophage TGF-P production, could be an interesting area of study.
Previous work has associated macrophage activation with increased TGF-,3 production (26). The mechanisms by which induction and activation of TGF-p8 occur during leishmanial infection are not understood. Of particular interest was the observation that local injection of rTGF-P3 could activate previous infection in which no lesion had developed or in which a healing response had already occurred. This suggests that TGF-,13 and/or other cytokines with similar or related activities may be responsible for the recurrence of quiescent L. braziliensis infections in humans. The concept that TGF-f3 may play a key role in the latency of L. braziliensis infections is further supported by results of in vitro studies, in which neutralizing anti-TGF-P mAb was found to lead to a decrease in otherwise static parasite levels (Fig. 2) . Taken together, the experiments suggest a role for parasite-induced TGF-43 in establishing and maintaining macrophage infection, as well as the importance of TGF-p levels in determining the degree of pathology.
Macrophage-activating cytokines, principally IFN-y and granulocyte/macrophage-colony-stimulating factor (16, (27) (28) (29) , as well as inactivating cytokines, including IL-10 and TGF-,3, can tightly control the intracellular replication of both leishmanias and T. cruzi in vitro and in vivo. The clinical implications of these findings are exciting and are especially important in parasitic diseases, for which the development of safe and effective therapeutics has been neglected.
